3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
21
Carcinoma, Non-Small-Cell Lung
12
Rectal Neoplasms
9
Glioblastoma
9
Esophageal Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
8
Stomach Neoplasms
7
Pancreatic Neoplasms
7
Lung Neoplasms
6
Head and Neck Neoplasms
6
Colorectal Neoplasms
5
Sarcoma
4
Ovarian Neoplasms
4
Neoplasms
4
Fallopian Tube Neoplasms
4
Colonic Neoplasms
3
Brain Neoplasms
3
Adenocarcinoma of Lung
3
Urinary Bladder Neoplasms
2
Osteosarcoma
2
Melanoma
2
Glioma
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Intraductal, Noninfiltrating
2
Carcinoma
2
Adenocarcinoma Of Esophagus
2
Xerostomia
1
Wilms Tumor
1
Urethral Neoplasms
1
Triple Negative Breast Neoplasms
1
Interventions
pembrolizumab
26
atezolizumab
14
Nivolumab
13
Gemcitabine
13
Cisplatin
10
Docetaxel
8
Carboplatin
8
avelumab
7
Mitomycin
7
epacadostat
4
cabozantinib
4
Ipilimumab
4
pemigatinib
3
Specimen Handling
3
Paclitaxel
3
Magnetic Resonance Spectroscopy
3
Bevacizumab
3
vofatamab
2
rucaparib
2
lenvatinib
2
enfortumab vedotin
2
durvalumab
2
cabazitaxel
2
bempegaldesleukin
2
Standard of Care
2
Rogaratinib
2
Ramucirumab
2
Radiation
2
Platinum
2
Pemetrexed
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Transitional Cell
×
Surgical Procedures, Operative
×
Clear all
No trials found.